FDA Approves Equine Firocoxib Tablets

Merial says the prescription tablets will be available on the market in early fall.
Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

The U.S. Food and Drug Administration (FDA) has approved a tablet form of firocoxib, which is currently available as a paste and injectable as Equioxx. Merial, which produces the product, said the tablets will be available on the market in early fall.

Equioxx, produced by Merial, is designed to control joint pain and inflammation associated with equine osteoarthritis. It is the only non-steroidal anti-inflammatory drug approved for use up to 14 days by both the American Quarter Horse Association and United States Equestrian Federation.

“Veterinarians and horse owners have been waiting for a tablet option of Equioxx from Merial,” says “The FDA approval process is very stringent, and we are proud to bring this new tablet formulation to market for horses,” said Hoyt Cheramie, DVM, MS, manager of Merial Large Animal Veterinary Services. “Having all three … formulations allows for consistent therapy with the same active ingredient.”

The Equioxx tablets will be available by prescription only

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

Where do you primarily feed your horse?
299 votes · 299 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!